RNA Therapies in Liver Disease: Insights from Ochre Bio’s CEO

In this interview, we speak with Jack O’Meara, co-founder and CEO of Ochre Bio, a pioneering force in liver disease treatment. O’Meara shares insights into Ochre Bio’s innovative RNA therapies, their approach to tackling liver disease, and the company’s vision for the future.

Fulfilling the promise of decentralized clinical trials

Finding the right tech partners can ease the pain points of running a DCT. Image credit: Foxy burrow via Shutterstock The uptake of decentralized clinical

May 30, 2024

STAT readers respond to First Opinion essays on site-neutral payments, free medical school tuition, and more

“Former HHS secretaries: Congress should adopt site-neutral payments for health care,” by Alex Azar and Kathleen G. Sebelius As a practicing oncologist, I wholeheartedly agree

April 27, 2024

Tuberculosis linked to increased risk of cancer, study finds

A population-wide observational study to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April)

April 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.